Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-01-12 @ 4:23 AM
Study NCT ID:
NCT01536405
Status:
COMPLETED
Last Update Posted:
2018-10-31
First Post:
2012-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2013-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-01-27
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-16
First Submit QC Date:
None
Study First Post Date:
2012-02-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-30
Results First Submit QC Date:
None
Results First Post Date:
2014-07-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-01
Last Update Post Date:
2018-10-31
Last Update Post Date Type:
ACTUAL